NEW YORK (GenomeWeb News) — Beckman Coulter closed its tender offer for $235 million in senior notes at the end of business yesterday, the company said today.
 
The company said the money raised from the offering would go toward paying debts, a large chunk of which coming from the acquisition of Lumigen, and it would use the rest of the funds to pay debts and fund research.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

This year's Breakthrough Prize winners include a pair that developed a therapy for spinal muscular atrophy.

The New York Times reports on how white supremacists misconstrue genetic research, concerning many geneticists.

Researchers find that people's genetics influence their success at university, but that it is not the only factor.

In Nature this week: approach to identify genetic variants that affect trait variability, application of read clouds to microbiome samples, and more.